• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[纤溶酶、微纤溶酶和纤维蛋白溶酶在模拟眼内出血中的溶栓作用]

[Thrombolytic effect of plasmin, miniplasmin and fibrinolysin in simulated intraocular hemorrhage].

作者信息

Metelitsyna I P, Petretskaia O S, Rodin S S, Andrianov S I

出版信息

Ukr Biokhim Zh (1978). 1993 Jan-Feb;65(1):93-7.

PMID:8351749
Abstract

The fibrinolytic properties of the preparations of plasmin (Pm), mixture of plasminogen and streptokinase (Pg+Sk), miniplasmin (m-Pm) and fibrinolysin have been investigated on the models of rabbit's hyphema. The action of preparations of Pm and Pg+Sk had approximately equal therapeutic index--the total destruction of clots proceeded for 12.0 days, that was 6.6 days less than in the control group. The therapeutic effect for m-Pm was 3.6 days. The dose of preparation of m-Pm, necessary for total destruction of clots, was 15-20% greater than for the same dose of Pg+Sk. The preparation of fibrinolysin, used in the same quantities of proteolytic activity, as Pg and m-Pg, (16 caseinolytic units per 1 injection) had no therapeutic effect.

摘要

在兔前房积血模型上研究了纤溶酶(Pm)制剂、纤溶酶原与链激酶混合物(Pg+Sk)、微型纤溶酶(m-Pm)和纤维蛋白溶酶制剂的纤溶特性。Pm和Pg+Sk制剂的作用具有大致相同的治疗指数——血栓完全溶解持续12.0天,比对照组少6.6天。m-Pm的治疗效果为3.6天。血栓完全溶解所需的m-Pm制剂剂量比相同剂量的Pg+Sk大15-20%。以与Pg和m-Pg相同的蛋白水解活性用量(每次注射16酪蛋白溶解单位)使用的纤维蛋白溶酶制剂没有治疗效果。

相似文献

1
[Thrombolytic effect of plasmin, miniplasmin and fibrinolysin in simulated intraocular hemorrhage].[纤溶酶、微纤溶酶和纤维蛋白溶酶在模拟眼内出血中的溶栓作用]
Ukr Biokhim Zh (1978). 1993 Jan-Feb;65(1):93-7.
2
[Degradation of streptokinase and the catalytic properties of the plasmin-streptokinase complex].[链激酶的降解及纤溶酶-链激酶复合物的催化特性]
Ukr Biokhim Zh (1999). 2002 May-Jun;74(3):50-7.
3
Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.纤溶酶-葡萄球菌激酶和纤溶酶(原)-链激酶激活复合物的体外动力学特性
Biochemistry (Mosc). 1999 Jan;64(1):66-74.
4
[Treatment of experimental hyphema in rabbits by Sevac plasmin].[用塞瓦克纤溶酶治疗兔实验性前房积血]
Cesk Oftalmol. 1973 Jan;29(1):3-10.
5
Coupling of conformational and proteolytic activation in the kinetic mechanism of plasminogen activation by streptokinase.链激酶激活纤溶酶原动力学机制中构象激活与蛋白水解激活的偶联
J Biol Chem. 2004 Aug 27;279(35):36642-9. doi: 10.1074/jbc.M405265200. Epub 2004 Jun 23.
6
[Experiences with the use of fibrinolysin and trypsin in intraocular hemorrhages].[纤维蛋白溶酶和胰蛋白酶在眼内出血中的应用经验]
Vestn Oftalmol. 1966 May-Jun;79(3):19-21.
7
Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.简化重组纤溶酶:一种新型溶栓分子与血浆源性纤溶酶的生产及功能比较
Thromb Haemost. 2008 Sep;100(3):413-9.
8
The thrombolytic effect of miniplasmin in a canine model of femoral artery thrombosis.微纤溶酶在犬股动脉血栓形成模型中的溶栓作用。
Thromb Res. 2008;122(5):683-90. doi: 10.1016/j.thromres.2008.01.007. Epub 2008 Mar 6.
9
Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis.酰基酶作为静脉血栓形成兔模型中的溶栓剂。
Thromb Haemost. 1982 Jun 28;47(3):269-74.
10
Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.深静脉血栓形成的溶栓治疗:纤溶酶的潜在应用
Thromb Res. 2009;123 Suppl 4:S56-61. doi: 10.1016/S0049-3848(09)70145-8.